EVENTS · ABUS
PEERS
EARNINGS
No company news, with biotechnology stocks broadly higher as the Health Care sector gained alongside a rising market
| Series | 1W | 1M |
|---|---|---|
| ABUS | −6.0% | −9.4% |
| Peers | +1.6% | +5.3% |
| Sector · Health Care | +5.6% | +13.5% |
| SPY | −0.7% | −1.6% |
| Percentile rank vs S&P 500 | 16 | 16 |
The company is offering to repurchase its own shares in a tender offer; holders choose whether to tender.
| Series | 1W | 1M |
|---|---|---|
| ABUS | −6.0% | −9.4% |
| Peers | +1.6% | +5.3% |
| Sector · Health Care | +5.6% | +13.5% |
| SPY | −0.7% | −1.6% |
| Percentile rank vs S&P 500 | 16 | 16 |
